• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于HIV-1蛋白酶抑制剂的计算研究:计算得到的抑制剂-酶结合亲和力对3D-QSAR CoMFA模型统计质量的影响。

Computational studies on HIV-1 protease inhibitors: influence of calculated inhibitor-enzyme binding affinities on the statistical quality of 3D-QSAR CoMFA models.

作者信息

Jayatilleke P R, Nair A C, Zauhar R, Welsh W J

机构信息

Department of Chemistry and Center for Molecular Electronics, University of Missouri-St. Louis, St. Louis, Missouri 63121, USA.

出版信息

J Med Chem. 2000 Nov 16;43(23):4446-51. doi: 10.1021/jm9905357.

DOI:10.1021/jm9905357
PMID:11087569
Abstract

A theoretical study was performed on a set of 38 human immunodeficiency type 1 (HIV-1) protease inhibitors that are structurally similar to the AIDS drug Indinavir. Comparison between the computed binding energies and experimental activity data (pIC(50)) found a high degree of correlation (r(2)() = 0.82). Three-dimensional quantitative structure-activity relationship (3D-QSAR) models using comparative molecular field analysis (CoMFA) yielded predicted activities that were in excellent agreement with the corresponding experimentally determined values. Inclusion of the calculated enzyme-inhibitor binding energy as an additional descriptor in the CoMFA model yielded a significant improvement in the internal predictive ability of our model (q(2)() = 0.45 to q(2)() = 0.69). Separate CoMFA models were constructed to evaluate the influence of different alignment schemes (Atom Fit and Field Fit) and different partial atomic charge assignment schemes (Discover CVFF, Gasteiger-Marsili, and AM1-ESP) on the statistical quality of the models.

摘要

对一组38种与艾滋病药物茚地那韦结构相似的1型人类免疫缺陷病毒(HIV-1)蛋白酶抑制剂进行了理论研究。计算得到的结合能与实验活性数据(pIC(50))之间的比较发现了高度相关性(r(2) = 0.82)。使用比较分子场分析(CoMFA)的三维定量构效关系(3D-QSAR)模型得出的预测活性与相应的实验测定值高度吻合。在CoMFA模型中纳入计算得到的酶-抑制剂结合能作为一个额外的描述符,使我们模型的内部预测能力有了显著提高(q(2)从0.45提高到0.69)。构建了单独的CoMFA模型,以评估不同对齐方案(原子拟合和场拟合)以及不同部分原子电荷分配方案(Discover CVFF、Gasteiger-Marsili和AM1-ESP)对模型统计质量的影响。

相似文献

1
Computational studies on HIV-1 protease inhibitors: influence of calculated inhibitor-enzyme binding affinities on the statistical quality of 3D-QSAR CoMFA models.关于HIV-1蛋白酶抑制剂的计算研究:计算得到的抑制剂-酶结合亲和力对3D-QSAR CoMFA模型统计质量的影响。
J Med Chem. 2000 Nov 16;43(23):4446-51. doi: 10.1021/jm9905357.
2
Computational studies on tetrahydropyrimidine-2-one HIV-1 protease inhibitors: improving three-dimensional quantitative structure-activity relationship comparative molecular field analysis models by inclusion of calculated inhibitor- and receptor-based properties.四氢嘧啶-2-酮HIV-1蛋白酶抑制剂的计算研究:通过纳入基于抑制剂和受体计算的性质改进三维定量构效关系比较分子场分析模型
J Med Chem. 2002 Feb 14;45(4):973-83. doi: 10.1021/jm010417v.
3
Molecular docking and 3D-QSAR studies of HIV-1 protease inhibitors.HIV-1 蛋白酶抑制剂的分子对接和 3D-QSAR 研究。
J Mol Model. 2010 Jul;16(7):1251-68. doi: 10.1007/s00894-009-0636-5. Epub 2010 Jan 13.
4
3D-QSAR CoMFA/CoMSIA models based on theoretical active conformers of HOE/BAY-793 analogs derived from HIV-1 protease inhibitor complexes.基于从 HIV-1 蛋白酶抑制剂复合物中得出的 HOE/BAY-793 类似物的理论活性构象的 3D-QSAR CoMFA/CoMSIA 模型。
Eur J Med Chem. 2009 Nov;44(11):4344-52. doi: 10.1016/j.ejmech.2009.05.016. Epub 2009 May 23.
5
Comparative molecular field analysis (CoMFA), topomer CoMFA, and hologram QSAR studies on a series of novel HIV-1 protease inhibitors.对一系列新型HIV-1蛋白酶抑制剂的比较分子场分析(CoMFA)、拓扑异构体CoMFA和全息定量构效关系研究。
Chem Biol Drug Des. 2017 Jun;89(6):918-931. doi: 10.1111/cbdd.12917. Epub 2017 Jan 30.
6
Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.利用分子场分析和分子对接研究绘制一大类喹唑啉型表皮生长因子受体(EGF-R)抑制剂的结合位点。
J Chem Inf Comput Sci. 2003 Jan-Feb;43(1):273-87. doi: 10.1021/ci025552a.
7
Three-dimensional QSAR of human immunodeficiency virus (I) protease inhibitors. 1. A CoMFA study employing experimentally-determined alignment rules.人类免疫缺陷病毒(I)蛋白酶抑制剂的三维定量构效关系。1. 一项采用实验确定的比对规则的比较分子场分析研究。
J Med Chem. 1993 Dec 24;36(26):4152-60. doi: 10.1021/jm00078a003.
8
Comparative molecular field analysis of a series of inhibitors of HIV-1 protease.对一系列 HIV-1 蛋白酶抑制剂的比较分子场分析。
Med Chem. 2011 Mar;7(2):71-9. doi: 10.2174/157340611794859370.
9
3D-QSAR of human immunodeficiency virus (I) protease inhibitors. III. Interpretation of CoMFA results.人类免疫缺陷病毒(I)蛋白酶抑制剂的3D-QSAR。III. CoMFA结果解读。
Drug Des Discov. 1994 Jul;12(1):29-51.
10
Multiple receptor conformation docking and dock pose clustering as tool for CoMFA and CoMSIA analysis - a case study on HIV-1 protease inhibitors.多种受体构象对接和对接构象聚类作为 CoMFA 和 CoMSIA 分析的工具 - 以 HIV-1 蛋白酶抑制剂为例。
J Mol Model. 2012 Feb;18(2):569-82. doi: 10.1007/s00894-011-1048-x. Epub 2011 May 6.

引用本文的文献

1
Design and Synthesis of Aminopyrimidinyl Pyrazole Analogs as PLK1 Inhibitors Using Hybrid 3D-QSAR and Molecular Docking.利用混合3D-QSAR和分子对接设计与合成作为PLK1抑制剂的氨基嘧啶基吡唑类似物
Pharmaceuticals (Basel). 2022 Sep 21;15(10):1170. doi: 10.3390/ph15101170.
2
Understanding electrostatic and steric requirements related to hypertensive action of AT(1) antagonists using molecular modeling techniques.运用分子建模技术理解与血管紧张素Ⅱ1型(AT(1))拮抗剂的高血压作用相关的静电和空间要求。
J Mol Model. 2014 Jul;20(7):2231. doi: 10.1007/s00894-014-2231-7. Epub 2014 Jun 17.
3
Proteochemometric modeling of the bioactivity spectra of HIV-1 protease inhibitors by introducing protein-ligand interaction fingerprint.
通过引入蛋白质-配体相互作用指纹,对 HIV-1 蛋白酶抑制剂的生物活性谱进行了定量构效关系建模。
PLoS One. 2012;7(7):e41698. doi: 10.1371/journal.pone.0041698. Epub 2012 Jul 27.
4
CoMFA and docking study of novel estrogen receptor subtype selective ligands.新型雌激素受体亚型选择性配体的比较分子力场分析和对接研究
J Comput Aided Mol Des. 2003 May-Jun;17(5-6):313-28. doi: 10.1023/a:1026104924132.
5
Improved prediction of HIV-1 protease-inhibitor binding energies by molecular dynamics simulations.通过分子动力学模拟改进对HIV-1蛋白酶抑制剂结合能的预测
BMC Struct Biol. 2003 Apr 1;3:2. doi: 10.1186/1472-6807-3-2.